Cryptococcal infection: host immunity, immune evasion and emerging immunotherapeutic strategies

Area of Science:

• * Infectious Diseases
• * Immunology
• * Mycology

Background:

• * Cryptococcal infection is a major opportunistic infection, particularly impacting immunocompromised populations.
• * *Cryptococcus* is a WHO priority fungal pathogen, with conventional antifungal treatments often failing due to its sophisticated immune evasion tactics.
• * Treatment failure highlights the urgent need for novel therapeutic approaches to overcome immune escape.

Purpose of the Study:

• * To review the host's pattern recognition receptors and immune responses during *Cryptococcus* infection.
• * To elucidate the immune evasion mechanisms utilized by *Cryptococcus*.
• * To explore the potential of immunotherapy as a strategy to combat cryptococcal infections in immunocompromised individuals.

Main Methods:

• * Comprehensive literature review focusing on host-pathogen interactions.
• * Analysis of innate and adaptive immune responses to *Cryptococcus*.
• * Examination of *Cryptococcus*'s immune evasion strategies and current immunotherapy research.

Main Results:

• * *Cryptococcus* employs complex strategies to evade host immune responses, contributing to treatment challenges.
• * Understanding host immune recognition (pattern recognition receptors) is crucial for developing effective therapies.
• * Immunotherapy presents a promising avenue for boosting host defenses against cryptococcal infections.

Conclusions:

• * Overcoming *Cryptococcus*'s immune evasion is critical for enhancing therapeutic outcomes.
• * Immunotherapeutic strategies hold significant potential for improving treatment efficacy in immunocompromised patients.
• * Further research into anti-cryptococcal immunotherapy is essential for developing new treatment paradigms.